Utah Medical Products (UTMD) Price to Earnings (2010 - 2026)

Utah Medical Products has reported Price to Earnings for 17 years, with the latest figure at 81.74 in Q2 2026.

• On a quarterly basis, Price to Earnings rose 36.11% year-over-year to 81.74 in Q2 2026; TTM through Jun 2026 was 22.24, a 48.38% increase from a year earlier, with the FY2025 full-year figure at 16.71, up 10.29% from the prior year.
• Price to Earnings was 81.74 for Q2 2026 at Utah Medical Products, up from 75.8 in the prior quarter.
• The five-year high for Price to Earnings was 92.94 in Q1 2022, with the low at 60.06 in Q2 2025.
• Average Price to Earnings over 5 years is 76.53, with a median of 78.0 recorded in 2023.
• The sharpest annual moves came in 2024 and 2026: Price to Earnings fell 20.95% in 2024, then jumped 36.11% in 2026.
• Over 5 years, Price to Earnings stood at 88.76 in 2022, then decreased by 6.07% to 83.37 in 2023, then retreated by 4.02% to 80.02 in 2024, then advanced by 14.15% to 91.34 in 2025, then declined by 10.5% to 81.74 in 2026.
• The last three Price to Earnings figures came in at 81.74 (Q2 2026), 75.8 (Q1 2026), and 91.34 (Q4 2025), per Business Quant data.